Exhibit 10.1
LEDGEMONT TECHNOLOGY CENTER
Lexington, Massachusetts
FOURTH AMENDMENT TO LEASE CYTEIR THERAPEUTICS, INC.
Fourth Amendment to Lease (“Fourth Amendment”) dated as of October 3 , 2023 between 99 Hayden LLC, a Delaware limited liability company (“Landlord”), and Cyteir Therapeutics, Inc., a Delaware corporation (“Tenant”).
Background
WHEREAS, Landlord’s predecessor in interest, 128 Spring Street Lexington, LLC, a Delaware limited liability company, and Tenant entered into a certain Lease dated August 8, 2018 (the “Original Lease”), as amended by that certain First Amendment to Lease dated as of October 15, 2019 (the “First Amendment”), Second Amendment to Lease dated July 1, 2021 (the “Second Amendment”), and Lease Amendment and Termination Agreement dated March 29, 2023 (the “Third Amendment”) (collectively the “Lease”), between Landlord and Tenant for certain premises consisting of approximately 5,531 rentable square feet of which is known as Suite 450 located on the 400 Level of the B Building (“Suite 450B”) (the “Premises”) of Ledgemont Technology Center at 99 Hayden Avenue, Lexington, Massachusetts (the “Building”). Capitalized terms used and not otherwise defined in this Fourth Amendment shall have the meanings ascribed to them in the Lease.
The Lease is scheduled to expire October 31, 2023. Landlord and Tenant desire to enter into this Fourth Amendment to extend the Term of the Lease on the terms more particularly set forth in this Fourth Amendment.
Agreement
FOR VALUE RECEIVED, Landlord and Tenant agree as follows:
1
Exhibit 10.1
450B of the Premises only shall be due and payable in a monthly installment as provided in the Lease, in the following amounts:
Month of Term | Monthly Base Rent |
November 1, 2023 – November 30, 2023 |
$14,057.96 |
(ii) Tenant has no rights to any credit, claim, cause of action, offset or similar charge against Landlord or the Base Rent existing as of the date hereof, and (iii) without Landlord’s prior written consent, there have been no assignees, sublessees or transferees of the Lease, or any person or firm occupying or having the right in the future to occupy the Premises, or any part thereof, except Tenant.
2
Exhibit 10.1
consent to a party’s accountants, attorneys, employees, agents, potential transferees and lenders, and others in privity with such party to the extent reasonably necessary for such party’s business purposes, or in connection with a dispute hereunder, provided that such party has been expressly advised of the confidential nature of such information.
3
Exhibit 10.1
EXECUTED as a sealed Massachusetts instrument as of the date first written above.
LANDLORD:
99 Hayden LLC,
a Delaware limited liability company
By: /s/ Peter Gottlieb
Name: Peter Gottlieb
Title: Manager
TENANT:
Cyteir Therapeutics, Inc., a Delaware corporation
By: /s/ Markus Renschler
Name: Markus Renschler
Title: President and CEO
4